A Proof of Concept Pilot Study of the Addition of Venetoclax to Standard Remission Induction Chemotherapy Fludarabine or Cladrabine, Cytarabine, and Granulocyte Colony Stimulating Factor (G-CSF) (FLAG or CLAG) for Frontline Therapy of Secondary Acute Myeloid Leukemia

NCT05780879 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Interim Analysis per Protocol

Conditions

Secondary Acute Myeloid Leukemia

Interventions

DRUG: Venetoclax
DRUG: FLAG or CLAG Protocol

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]